Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-25 @ 9:51 PM
Study NCT ID:
NCT03407651
Status:
COMPLETED
Last Update Posted:
2021-09-23
First Post:
2018-01-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
Sponsor:
Catalyst Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-04
First Submit QC Date:
None
Study First Post Date:
2018-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-25
Results First Submit QC Date:
None
Results First Post Date:
2021-09-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-21
Last Update Post Date:
2021-09-23
Last Update Post Date Type:
ACTUAL